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Abstract
Background: The unfolded protein response (UPR) is activated following an endoplasmic reticulum (ER) stress. The
aim of this study was to investigate the global expression of UPR genes in human OA chondrocytes in induced
(I)-UPR conditions, and to explore the regulation and role of the UPR genes in homeostatic (H)-UPR conditions in
human normal and OA chondrocytes.
Methods: Gene expression was determined by PCR array and qPCR. Protein production in cartilage was determined
by immunohistochemistry, gene silencing by specific siRNAs, and gene regulation by treating chondrocytes with
cytokines and growth factors associated with cartilage pathobiology.
Results: Several UPR genes, among them ERN1, PERK, and CREB3L2 were downregulated in OA compared to
normal chondrocytes at both the mRNA and protein levels, but the ER stress response triggered by thapsigargin
or tunicamycin treatment was similar in normal and OA chondrocytes. The activation of ER stress sensors
(phosphorylated PERK, cleavage of ATF6B, and the spliced mRNA forms of XBP1) was not significantly increased in
OA chondrocytes/cartilage. PDGF-BB and IL-6 significantly downregulated the expression of ERN1, PERK, and
CREB3L2, but not that of ATF6B. Silencing experiments done under conditions of no ER stress (physiological
conditions) revealed that decreasing ERN1 expression led to decreased COL2a1, MMP-13, ADAMTS4 and ADAMTS5
expression, while decreasing CREB3L2 and ATF6B led to decreased ADAMTS5 and ADAMTS4 expression, respectively.
Importantly, the downregulation of PERK expression increased COL1a1 and suppressed COL2a1 expression.
Conclusions: Although the level of ER stress is not significantly increased in OA chondrocytes, these cells respond
strongly to an acute ER stress despite the decreased expression of ERN1, PERK, and CREB3L2. Emerging findings
revealed for the first time that these genes play a role in cartilage biology in conditions where an acute ER stress
response is not triggered and OA is not characterized by an overall basal activation of the ER stress response.
Importantly, these findings identify PERK as a potential target for new OA treatment avenues.
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Background
Osteoarthritis (OA) is a progressive disease of the joints
resulting in the degradation of articular cartilage.
Several signalling pathways, transcription factors, and
cytokines contribute to the progression of this disease,
and it is likely that other molecules will be discovered
as well, as more is yet to be learned to fully understand
this pathology.
The endoplasmic reticulum (ER) stress response has
attracted attention as a new area of research in OA cartil-
age biology. ER stress can be triggered by oxidative stress,
heat shock, hypoxia, expression of mutant proteins
and drugs such as thapsigargin (Tg), which disrupts ER
calcium ion balance [1], and tunicamycin (Tm), which
inhibits N-linked glycosylation [2]. The cellular response,
known as the unfolded protein response (UPR), serves to
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counter the stresses that occur by the presence of mis-
folded proteins in the ER in an attempt to restore homeo-
stasis [3–8]. Three major families of ER stress sensors
have been identified in mammalian cells: the endoplasmic
reticulum to nucleus 1 (ERN1, also called IRE1), PRKR-
like endoplasmic reticulum kinase (PERK, or EIF2AK3),
and activating transcription factor 6 (ATF6). The ATF6
family comprises several members, among them ATF6B,
CAMP-responsive element-binding protein 3-like 2
(CREB3L2), and old astrocyte specifically induced sub-
stance (OASIS), which are involved in different cellular
processes or expressed preferentially depending on cell
type [9, 10]. As an example, CREB3L2 has been identi-
fied as a transcription factor expressed strongly in
chondrocytes [11]. Accumulation of unfolded proteins
in the ER initiates the activation of ERN1, PERK, and
ATF6, leading to the upregulation of several genes such
as the glucose-regulated protein 78 (GRP78 or BiP or
HSPA5), a chaperone that binds preferentially to the
unfolded proteins.
Accumulative evidence has implicated UPR proteins in
physiological processes beyond the control of protein
folding [7]. In those instances, ERN1, PERK, and ATF6
can be activated without the presence of misfolded pro-
teins and the dissociation of GRP78, and the final outcome
is different from that triggered by the ER stress [12, 13].
Drug discovery efforts have recently identified the UPR
proteins as therapeutic targets to treat several diseases
[14]. However, although the expression and roles of some
individual UPR genes have been investigated in OA
[15, 16], the global response of chondrocytes to ER
stress has not been looked at. The present study had two
major aims. The first one was the evaluation of the global
expression of the UPR genes in normal and OA chon-
drocytes in response to an induced ER stress (I-UPR
conditions) in order to assess their impact during OA.
Importantly, our second aim was to examine how the de-
regulation of the major representative ER stress sensors
could affect cartilage metabolism under conditions where
an ER stress is not induced (homeostatic or H-UPR).
Methods
Specimen selection
Human normal cartilage was obtained from femoral con-
dyles and tibial plateaus from individuals within 12 hours
of death (n = 18, 60 ± 19 years [mean age ± standard devi-
ation (SD)]) and OA cartilage from patients undergoing
total knee arthroplasty (n = 42, 69 ± 9 years). Human nor-
mal individuals had no history of joint disease and died of
causes unrelated to arthritic diseases. The cartilage was
examined macroscopically and microscopically to ensure
that only normal tissue was used. All OA patients had
been evaluated by a certified rheumatologist and diag-
nosed as having OA according to the American College of
Rheumatology criteria [17]. These specimens represented
moderate-to-severe OA. The Institutional Ethics Commit-
tee Board of the University of Montreal Hospital Research
Centre (CRCHUM) approved the use of the human ar-
ticular tissues and patients signed informed consent.
Cell culture
Human chondrocytes were released from the cartilage as
described [18], seeded at high density (105/cm2), and
cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Wisent, St-Bruno, QC, Canada) supplemented with 10 %
heat-inactivated fetal bovine serum (FBS; PAA Laborator-
ies Inc., Etobicoke, ON, Canada) and an antibiotic mixture
(100 units/ml penicillin base and 100 μg/ml streptomycin
base; Wisent) at 37 °C in a humidified atmosphere of 5 %
CO2/95 % air. To preserve the chondrocyte phenotype,
primary cells were used when comparing expression levels
in normal and OA chondrocytes, and first-passage for ex-
periments involving cultured cells. Of note, the cartilage
and chondrocyte data are representative of independent
assays and ‘n’ indicates the number of different patients.
An ER stress response was triggered by treating chon-
drocytes with Tm (500 ng/ml) or Tg (50 nM) for 20 hours
in DMEM containing 10 % fetal bovine serum (FBS);
under those conditions, neither Tg nor Tm affected cell
viability (n = 8) as determined by the Thiazolyl Blue Tetra-
zolium Bromide (MTT, Sigma-Aldrich, Oakville, ON,
Canada) assay as described [19] with modification [20].
The basal activation of the ER stress response in OA
chondrocytes was determined by monitoring the three
main sensors (ERN1, PERK, and ATF6B). OA chondro-
cytes were incubated without (basal control) and with Tg
(50 nM) and Tm (500 ng/ml) for 20 minutes as controls
for induced ER stress activation. The phosphorylation sta-
tus of PERK was assessed by immunohistochemistry
(IHC), the cleavage of ATF6B was assessed by Western
blots using a specific antibody (see below), and the spliced
forms of X-box binding protein 1 (XBP1) (target of ERN1)
were monitored by polymerase chain reaction (PCR) using
specific primers.
Gene regulation was performed by treating cells with
growth factors and cytokines for 24 hours in DMEM
containing 0.5 % FBS. Activin A (ActA), transforming
growth factor beta (TGF-β), platelet-derived growth factor-
BB (PDGF-BB), interleukin-4 (IL-4), IL-6, and IL-8 were
used at a concentration of 10 ng/ml, IL-1β at 100 pg/ml,
and tumour necrosis factor alpha (TNF-α) at 5 ng/ml.
PCR array
Overall expression of 84 key UPR genes was determined
with the RT2 Profiler PCR Arrays (PAHS-089Z; Qiagen,
Venlo, The Netherlands) on an ABI 7900HT qPCR in-
strument (Applied Biosystems, Foster City, CA, USA)
equipped with SDS 2.3 software, using RT2 SYBR Green
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ROX qPCR Master Mix (Qiagen). Total ribonucleic
acid (RNA) from human chondrocytes was isolated and
reverse-transcribed according to the manufacturer’s in-
structions. Data were analyzed by the 2-ΔΔCt method.
The relative quantity of complementary deoxyribonucleic
acid (cDNA) was calculated using ribosomal protein large
PO (RPLPO) as internal controls. All the PCR array data
have been submitted to the Gene Expression Omnibus
(GEO) public repository with the accession numbers
GSE73749 (normal versus OA), GSE73748 (effect of Tm)
and GSE73746 (effect of Tg).
Quantification of mRNA and qPCR
Total RNA was extracted and messenger RNA (mRNA)
levels quantified by real-time PCR (qPCR) with the SYBR
Green PCR Master Mix (Qiagen) as described [21]. For
total RNA quantification of expression between normal
and OA chondrocytes, internal standards were added at
known concentrations in the PCR reactions so as to give
absolute numbers. The values of each sample were calcu-
lated as the ratio of the number of molecules of the target
gene/number of molecules of the housekeeping gene.
When evaluating the effect of a treatment, the expression
level of each control was assigned an arbitrary value of 1,
and the treated cells were evaluated as fold change over
control and calculated as 2-ΔΔCt. Primer efficiencies for
the genes under study were the same as those for the
housekeeping gene, RPLPO. The sequences of the human
specific primers used are listed in Additional file 1.
Immunohistochemistry
The localization of ERN1, PERK, ATF6B, and CREB3L2
in normal and OA cartilage was determined by IHC as
previously described [22]. In brief, the cartilage was fixed
in TissuFix (Chaptec, Montreal, QC, Canada) and em-
bedded in paraffin. Sections (5 μm) were deparaffinized
in xylene followed by a graded series of alcohol
washes. Sections were treated with 1 % hyaluronidase
for 60 minutes at 37 °C (ERN1 only), 0.25 units/ml
protease-free chondroitinase ABC in 0.1 M Tris acetate
(Sigma-Aldrich), 0.3 % Triton for 30 minutes and 3 %
H2O2 for 15 minutes at room temperature and proteinase
K (20 μg/ml, 10 minutes at 37 °C for CREB3L2 only).
2 % goat serum (Vector Laboratories, Burlington, ON,
Canada) was used for 45 minutes at room temperature
to block unspecific staining prior to the addition of the
primary antibodies.
The primary antibodies were diluted in goat serum
and incubated overnight at 4 °C. Primary antibodies were
all rabbit anti-human against ERN1 (monoclonal im-
munoglobulin G (IgG) 1/50; Cell Signaling Technology,
Danvers, MA, USA), PERK (monoclonal IgG 1/100; Cell
Signaling Technology), phosphorylated PERK (pPERK)
(polyclonal IgG, 1/50, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), ATF6B (polyclonal IgG 1/100; Abcam,
Cambridge, MA, USA), and CREB3L2 (polyclonal IgG
1/25; Santa Cruz Biotechnology). The tissues were washed
in phosphate-buffered saline (PBS), then incubated with a
secondary anti-rabbit antibody using a Vectastain
ABC kit (Vector Laboratories) following the manufac-
turer’s instructions. The staining was developed with
3,3′-diaminobenzidine containing hydrogen peroxide,
and sections were counterstained with eosin (0.03 %
in 80 % ethanol). The eosin staining offers a good cell
contrast allowing visualization of all the cells. Control
procedures were performed by a substitution of the
primary antibody with a nonspecific rabbit IgG (Santa
Cruz Biotechnology) following the same experimental
protocol; the results showed only background staining
as illustrated in Additional file 2.
Antigen levels were quantified as described [22]. The
total number of chondrocytes and the number of positively
stained chondrocytes were quantitated separately for each
zone of the cartilage. The final results are expressed as the
percentage of positively stained chondrocytes.
Gene silencing
Small interfering RNA (siRNA; Ambion-Life Technologies,
Waltham, MA, USA) specific for the genes under study
were transfected into the chondrocytes as described
[21] for 48 hours (gene expression) or 72 hours (protein
production). Cells either non-transfected or transfected
with non-targeting (random) siRNAs (ON-TARGETplus
Non-targeting siRNA; Dharmacon, Lafayette, CO, USA)
served as controls and gave similar results. RNA was
quantitated by qPCR and data normalized to the house-
keeping gene RPLPO. When monitoring the effect of
IL-1β on gene expression in the silenced chondrocytes,
the cells were first transfected for 24 hours with the
siRNAs, then IL-1β (100 pg/ml) was added and the cells
incubated for another 24 hours in DMEM containing
0.5 % FBS.
Western blotting
Total cellular proteins were extracted and processed for
Western blotting as described [23]. For the silencing
experiments, the primary antibodies were those used for
the IHC assays with dilutions of 1/2000 (ERN1), 1/1000
(PERK and ATF6B) and 1/100 (CREB3L2). The second-
ary antibody was an anti-rabbit IgG (1/10,000; Pierce,
Rockford, IL, USA). Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (monoclonal IgG, 1/20,000, Cell Signal-
ing Technology) was used as the housekeeping (control)
protein.
Statistical analysis
Values are expressed as mean ± standard error of the
mean (SEM). Statistical significance was assessed with
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the unpaired t test or a one-sample t test where appro-
priate; a p value ≤0.05 was considered significant.
Results
Several UPR genes are differentially expressed between
normal and OA chondrocytes
The PCR array was first used to give an overview of the
differential expression of the UPR genes in normal (n = 3)
and OA (n = 3) chondrocytes. Table 1A lists the genes
having a 1.3-fold expression change in OA compared to
normal chondrocytes. Among the genes differentially
expressed in OA are ERN1 and GRP78, which were down-
regulated. The expression of PERK was also downregu-
lated to -1.2-fold, but the expression of ATF6 and ATF6B
was unchanged.
Validation by qPCR (Fig. 1) was performed for the
representatives of the three main branches of the ER
stress response, ERN1, PERK, and ATF6B, a member of
the ATF6 family. Data include CREB3L2, also a member
of the ATF6 family [10]. Data confirm that ERN1 (Fig. 1a)
and PERK (Fig. 1b) expression was significantly decreased
in OA (n = 6) compared to normal (n = 6) chondrocytes.
ATF6B (Fig. 1c) was similarly expressed in normal and
OA chondrocytes, but CREB3L2 expression (Fig. 1d) was
significantly decreased in OA chondrocytes.
Next, we looked at whether the expression of ERN1,
PERK, ATF6B, and CREB3L2 was reflected in protein
production by performing IHC directly on cartilage to
determine both the amount and location in the cartilage
of the proteins tested. The number of chondrocytes that
stained positive for ERN1 (Fig. 1a) and ATF6B (Fig. 1c),
was less than 5 % in the lower zone of the cartilage,
whereas PERK (Fig. 1b) and CREB3L2 (Fig. 1d) were
detected in both the upper and lower zones of the car-
tilage, although at a reduced level in the lower zone
compared to the upper zone. ERN1, PERK, and CREB3L2
production was significantly reduced in the upper zone of
the OA cartilage, but ATF6B was similar in both normal
and OA cartilage. The IHC data (from cartilage) mirrored
the qPCR data (from isolated chondrocytes), indicating
that the expression/production of the representatives of
the three main branches of the ER stress response are
downregulated in OA chondrocytes/cartilage.
Basal activation status of the ER stress response in OA
chondrocytes
The basal activation status of the three main branches of
the ER stress response (phosphorylation of PERK, cleav-
age of ATF6B and splicing of XBP1, a target of ERN1)
was monitored in untreated OA cells. The presence of
phosphorylated PERK was determined by IHC in normal
and OA cartilage, the ATF6B total protein by Western
blot in OA chondrocytes, and XBP1 splicing by PCR in
OA chondrocytes. Although data (Fig. 2a) showed that
the levels of phosphorylated PERK were slightly de-
creased in OA compared to normal cartilage, the dif-
ference did not reach statistical significance.
When activated by ER stress, ATF6B (approximately
75 kDa) is cleaved into fragments, one of which acts as a
transcription factor following its transfer to the nucleus.
The cleavage of ATF6B was assayed by Western blot
with an antibody recognizing the C-terminus of the
protein. Samples treated with Tg (50 nM) and Tm
(500 ng/ml), agents well known to induce an ER stress
response (I-UPR conditions), were included as controls
for the cleavage of the protein. As illustrated in Fig. 2b,
Tg or Tm treatments significantly reduced the levels of
the uncleaved ATF6B in OA chondrocytes, suggesting
that if activated, it is not at its maximal levels. Although
the antibody could in theory also detect the small cleaved
fragment, under our experimental conditions this fragment
was barely detectable, possibly due to further degradation.
The presence of the XBP1-spliced mRNA was deter-
mined by PCR with primers that amplify both the unspliced
(amplification product of 145 bp) and spliced (amplification
product of 119 bp) forms. Samples treated with Tg
(50 nM) and Tm (500 ng/ml) were also included as
controls of XBP1 mRNA splicing. Data (Fig. 2c) show
that the unspliced mRNA was the only XBP1 mRNA
species detected in all the untreated OA cells. This is
in contrast to the Tg- and Tm-treated OA chondrocytes,
which showed only the activated (spliced) XBP1 mRNA
species.
Taken together, these results indicate that the ER
stress response is not globally or fully activated in OA
chondrocytes.
Regulation of UPR genes under I-UPR conditions in normal
and OA chondrocytes
Next, we assessed whether the decreased expression of
some UPR genes in OA chondrocytes affected the in-
duced ER stress response. To this end, OA chondrocytes
(n = 3) were incubated with Tg (50 nM) and Tm
(500 ng/ml). Table 1B and C list the UPR genes having
1.3-fold change expression for Tg and Tm treatments,
respectively. The greatest increased expression was ob-
served with GRP78 (target gene of ERN1 and ATF6) and
DNA damage-inducible transcript 3 (DDIT3) (CHOP,
target gene of PERK) [6, 7]. Increased expression was
also noted with the homocysteine-inducible, endoplasmic
reticulum stress-inducible, ubiquitin-like domain member
1 (HERPUD1), DnaJ (Hsp40) homolog, subfamily B,
member 9 (DNAJB9), and ERO1-like beta (S. Cerevisiae)
(ERO1LB) genes, which are the targets of CREB3L2 [11].
These results indicate that the OA chondrocytes could
respond strongly to acute ER stress. Validation of OA
chondrocytes (n = 6–12) by qPCR (Table 2) also resulted
in significantly increased expression of GRP78, CHOP,
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DNAJB9, ERN1, and PERK; ATF6B, CREB3L2, and sterol
regulatory element-binding protein 2 (SREBP2) (with Tg)
expression was not significantly affected. Treatment of nor-
mal chondrocytes (n = 4) with Tg and Tm showed a similar
level of response to that observed in OA chondrocytes
Table 1 UPR genes having 1.3-fold change expression in
human chondrocytes as determined by PCR array*
Increased expression Decreased expression
A) Osteoarthritic chondrocytes (n = 3) compared to normal
chondrocytes (n = 3)
SREBF2 4.71 CEBPB -1.98
ERN2 1.81 UBE2G2 -1.87
ATXN3 1.61 HTRA4 -1.84
SCAP 1.57 NPLOC4 -1.73
SREBF1 1.52 ERN1 -1.71
PDIA3 1.49 DNAJB9 -1.60
ERO1L 1.48 GRP78 (HSPA5) -1.59
HSPA4L 1.46 INSIG1 -1.51
DNAJB2 1.45 XBP1 -1.38







B) Osteoarthritic chondrocytes (n = 3) treated with thapsigargin (50 nM)
compared to untreated (control) chondrocytes
GRP78 (HSPA5) 26.01 PRKCSH -4.37
CHOP (DDIT3) 20.76 SREBF1 -4.18
HERPUD1 16.88 MAPK10 -3.58
DNAJB9 14.39 HSPA2 -2.66
ERO1LB 13.90 PPIA -2.57
MANF 8.69 HSPA4L -2.18
PPP1R15A 6.98 FBXO6 -2.11
SEL1L 6.76 HSPA1L -1.98
ERN1 (IRE1) 6.10 PFDN5 -1.91
SYVN1 5.99 MAPK9 -1.84
SERP1 4.98 GANC -1.81
EDEM1 4.55 HTRA4 -1.77
SELS 4.49 CCT7 -1.75
PERK (EIF2AK3) 4.15 HSPA1B -1.71
DERL2 3.90 INSIG1 -1.70
DNAJC3 3.67 NPLOC4 -1.64
PDIA3 2.81 BAX -1.62
SEC63 2.54 HSPA4 -1.58
DNAJC10 2.48 DNAJB2 -1.57
DERL1 2.27 TOR1A -1.55
ATF4 2.17 UBE2G2 -1.51
CALR 2.13 MBTPS1 -1.45
XBP1 1.98 GANAB -1.43
Table 1 UPR genes having 1.3-fold change expression in
human chondrocytes as determined by PCR array* (Continued)
ERP44 1.89 SREBF2 -1.39
ERO1L 1.75 ERN2 -1.36
VCP 1.72 HSPH1 -1.35
UGGT1 1.60 AMFR -1.35
ATF6 1.54 SIL1 -1.31




C) Osteoarthritic chondrocytes (n = 3) treated with tunicamycin (500 ng/ml)
compared to untreated (control) chondrocytes
GRP78 (HSPA5) 21.89 SREBF1 -3.79
CHOP (DDIT3) 15.69 INSIG1 -3.17
HERPUD1 11.67 HSPA2 -2.77
ERO1LB 10.34 PPIA -2.27
DNAJB9 9.44 HSPA4L -2.03
MANF 6.76 PRKCSH -1.97
SEL1L 5.66 HTRA4 -1.95
ERN1 (IRE1) 4.57 SREBF2 -1.94
SERP1 3.94 FBXO6 -1.91
PPP1R15A 3.75 NPLOC4 -1.74
DNAJC3 3.67 MAPK10 -1.70
SYVN1 3.58 MAPK9 -1.63
EDEM1 3.53 CCT7 -1.62
SELS 3.34 PFDN5 -1.61
DERL2 3.04 HSPA1B -1.60
PERK (EIF2AK3) 2.27 HSPH1 -1.59
ATF4 2.20 GANC -1.57
PDIA3 2.09 ERN2 -1.47
SEC63 2.03 HSPA4 -1.46
DNAJC10 2.01 TOR1A -1.46
CALR 1.86 INSIG2 -1.41
DERL1 1.80 UDF1L -1.40
ERP44 1.59 TCP1 -1.39




*The RPLPO gene was used as the housekeeping reference gene. Genes in
bold are those cited in the text
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(Table 2) and data revealed no significant differences be-
tween them. These results indicate that ERN1 and PERK,
despite their decreased expression in OA chondrocytes
(Fig. 1), could be activated and trigger a strong response.
Regulation and role of UPR genes under H-UPR conditions
As the role of UPR proteins under I-UPR conditions has
already been investigated [24–26], we further explored
the regulation and role of the UPR genes under H-UPR
Fig. 1 Expression/production of UPR genes in normal and osteoarthritic (OA) human chondrocytes and cartilage. mRNA levels (qPCR, normal
[n = 6)] and OA [n = 6]) and protein production (immunohistochemistry [IHC], normal [n = 7] and OA [n = 7]) of (a) ERN1, (b) PERK, (c) ATF6B,
and (d) CREB3L2. Illustrated are representative images of cartilage IHC. Data are expressed as mean ± SEM, and p values assessed by the unpaired t test
comparing OA to normal chondrocytes. Magnification × 63 (a, b) and × 250 (c and d, upper cartilage zone; e and f, lower zone); boxes indicate where
the magnifications were taken, and arrows indicate positively stained chondrocytes
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conditions. To this end, we hypothesized that some of
those proteins played a role under H-UPR conditions,
different from those under I-UPR. We first looked at
factors that could be responsible, under homeostatic
conditions, for the downregulation of ERN1, PERK, and
CREB3L2 in OA chondrocytes and secondly determined
their potential role in regulation of genes involved in
OA pathology.
Fig. 2 Basal activation status of the ER stress sensors in osteoarthritic (OA) chondrocytes. a The phosphorylation of PERK was determined by
immunohistochemistry (IHC) in normal (n = 7) and OA (n = 7) cartilage. Illustrated are representative images of cartilage IHC and a graph of the
data expressed as mean ± SEM. Statistical significance assessed by the unpaired t test comparing OA to normal chondrocytes showed no difference.
Magnification × 63 (a, b) and × 250 (c and d, upper cartilage zone; e and f, lower zone); boxes indicate where the magnifications were taken, and
arrows, the positively stained chondrocytes. b The uncleaved form (approximately 75 kDa) of ATF6B in OA chondrocytes (n = 6) treated or not
(control) for 20 minutes with thapsigargin (Tg; 50 nM) and tunicamycin (Tm; 500 ng/ml) assessed by Western blot using an antibody that recognizes
the C-terminus of the protein. Illustrated are representative Western blots with GAPDH as loading control and a graph of the densitometry analysis of
the uncleaved ATF6B. Data are expressed as mean ± SEM, and p values assessed by the unpaired t test comparing OA to normal chondrocytes.
c The presence of the spliced form of XBP1 mRNA was determined by PCR followed by gel electrophoresis (n = 8). In addition, OA chondrocyte sample
#8 treated for 20 minutes with Tg (50 nM) and Tm (500 ng/ml) is shown as control for the ER stress activation
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ERN1, PERK, and CREB3L2 expression is downregulated by
PDGF-BB and IL-6 in OA chondrocytes
OA chondrocytes (n = 5–7) were treated with cytokines
and growth factors known to be associated with cartilage
pathobiology and their effect on ERN1, PERK, ATF6B, and
CREB3L2 was assessed. Data (Fig. 3) revealed that IL-1β
significantly increased ERN1 and PERK expression. Inter-
estingly, PDGF-BB and IL-6 significantly decreased ERN1,
PERK, and CREB3L2, while IL-4 significantly decreased
only ERN1 gene expression. ATF6B, unlike CREB3L2, was
not significantly affected by the factors studied. It is inter-
esting to note that members of the ATF6 family (ATF6,
ATF6B, and CREB3L2) are not only differentially expressed
in OA chondrocytes (Fig. 1), but are also differentially regu-
lated (Fig. 3). Thus, although members of the ATF6 family
share similar functions as effectors of ER stress, CREB3L2
may be the factor of choice in human chondrocytes for
fine-tuning the regulation of ER stress.
Table 2 Expression of UPR genes in response to treatment with thapsigargin and tunicamycin in human chondrocytes
Tg Tm
Normal p value OA p value Normal p value OA p value
ERN1 5.29 ± 1.49 0.063 7.15 ± 0.61 ≤0.001 3.76 ± 1.12 0.089 4.12 ± 0.36 ≤0.001
PERK 3.54 ± 0.34 0.005 2.52 ± 0.21 ≤0.001 2.18 ± 0.48 0.089 1.59 ± 0.12 0.006
ATF6B 1.05 ± 0.06 0.446 0.82 ± 0.08 0.074 1.07 ± 0.30 0.837 0.86 ± 0.12 0.325
CREB3L2 1.15 ± 0.26 0.606 1.38 ± 0.34 0.307 1.15 ± 0.20 0.502 1.20 ± 0.16 0.271
GRP78 38.54 ± 6.27 0.009 35.68 ± 4.45 ≤0.001 19.18 ± 2.40 0.005 16.74 ± 2.31 ≤0.001
CHOP 22.08 ± 6.72 0.052 25.64 ± 6.49 0.012 13.66 ± 3.06 0.025 6.34 ± 1.66 0.023
DNAJB9 15.04 ± 4.37 0.049 12.33 ± 1.77 ≤0.001 9.56 ± 2.86 0.009 7.76 ± 0.75 ≤0.001
SREBP2 0.79 ± 0.11 0.165 0.84 ± 0.11 0.200 0.51 ± 0.09 0.013 0.68 ± 0.09 0.015
The normal (n = 4) and osteoarthritic (OA; n = 6–12) chondrocytes were treated for 20 hours with thapsigargin (Tg; 50 nM) and tunicamycin (Tm; 500 ng/ml) and
processed for qPCR. Each untreated control was assigned an arbitrary value of 1. The effect of each treatment was evaluated as fold change over control and
expressed as mean values ± SEM. p values were assessed by the one-sample t test, comparing the treated chondrocytes to the untreated controls (arbitrary value
of 1); values ≤0.05 were considered significant. Comparison between normal and OA was assessed by the Mann-Whitney test; data revealed no significant differences
(p values not shown)
Fig. 3 Regulation of UPR genes by cytokines/growth factors in human osteoarthritic chondrocytes under H-UPR conditions. Chondrocytes (n = 5–7)
were treated with the following factors: Activin A (ActA), TGF-β, PDGF-BB, IL-4, IL-6, and IL-8 (all at 10 ng/ml), IL-1β (100 pg/ml), and TNF-α (5 ng/ml)
and processed for RNA extraction and qPCR. Each control (untreated cells) was assigned an arbitrary value of 1 and the effect of the treatment
evaluated as fold change over control. Data are expressed as mean ± SEM, and p values assessed by the one-sample t test, comparing the treated
chondrocytes to the control
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We have shown that the expression of ERN1 and
PERK was decreased in OA cells and that IL-1β increased
PERK and ERN1 expression. As IL-1β is known to be in-
creased in OA [27], we further determined whether the
presence of PDGF-BB and IL-6 could interfere with the
upregulation of ERN1 and PERK by IL-1β. To this end,
OA chondrocytes were monitored for the expression of
IL-1β following PDGF-BB and IL-6 treatments. Data
show that treatment of OA chondrocytes with PDGF-BB
resulted in a significantly decreased expression of IL-1β
(n = 6, mean fold change over control ± SEM 0.50 ± 0.13,
p = 0.013 [one-sample t test]), but that treatment with
IL-6 did not significantly affect IL-1β expression (n = 6,
1.8 ± 1.0, p = 0.437). These results show that the pres-
ence of PDGF-BB can interfere with the expression
levels of IL-1β and ultimately those of ERN1 and PERK.
ERN1, PERK, ATF6B, and CREB3L2 regulate collagen and
protease gene expression
We next determined whether ERN1, PERK, ATF6B, and
CREB3L2 affected the expression of genes involved in OA
pathology. The genes of interest were silenced with specific
siRNAs and the effect assessed on the expression of
types I (COL1a1) and II (COL2a1) collagens, matrix
metalloproteinases (MMP)-1 and MMP-13, and a disin-
tegrin and metalloproteinase with thrombospondin motifs
(ADAMTS)4 and ADAMTS5. As illustrated in Fig. 4a, si-
lencing ERN1 induced a decreased expression of COL2a1,
MMP-13, ADAMTS4, and ADAMTS5, ATF6B signifi-
cantly decreased expression of ADAMTS4, and CREB3L2
the expression of ADAMTS5. Interestingly, silencing
PERK resulted in a significant increase in the expres-
sion of COL1a1 and a significant decrease in COL2a1
gene expression.
Thus, under H-UPR conditions, increasing PERK may
contribute to an increase in type II collagen and a de-
crease in type I collagen expression, whereas increasing
ERN1, ATF6B, and CREB3L2 could have detrimental ef-
fects as they would upregulate MMP-13, ADAMTS4,
and ADAMTS5, known catabolic factors involved in car-
tilage destruction.
As IL-1β is an important factor in the regulation of
collagen and protease genes, we examined whether the
decreased expression of ERN1, PERK, ATF6B, or CREB3L2
affected its action. IL-1β significantly reduced COL2a1 and
increased MMP-13 (data not shown), ADAMTS4, and
ADAMTS5 expression (Fig. 4b), but did not affect COL1a1
expression (data not shown). Silencing ERN1 did not affect
the stimulatory effect of IL-1β on MMP-13 and ADAMTS4
or its inhibitory effect on COL2a1 (data not shown).
IL-1β did not maximally stimulate ADAMTS4 in the si-
lenced ATF6B or ADAMTS5 in the silenced CREB3L2
chondrocytes (Fig. 4b). IL-1β did not affect COL1a1 in
PERK-silenced chondrocytes (data not shown), but
significantly reduced COL2a1 (Fig. 4b). Thus, a lower ex-
pression of PERK has a twofold effect: it reduces COL2a1
expression and, in the presence of IL-1β such as occurs in
OA, the COL2a1 expression is further reduced.
Discussion
The event that triggers the initiation of OA is still a
matter of intense research. OA is a multifactorial process
with several factors contributing to the degradation of the
cartilage. In this work, we examined whether OA was
characterized by an overall activation of the ER stress re-
sponse. We first looked at the global expression of UPR
genes in human OA chondrocytes, the activation status of
the ER stress sensors, and the response of OA cells under
induced (I)-UPR conditions. We found that despite the
decreased expression/production of several UPR genes in
OA, the global induced ER stress response is similar to
that of normal chondrocytes, and that the three main sen-
sors of the ER stress were not activated or fully activated
in OA cells. Based on these data, OA is not likely the re-
sult of an overall activation of the ER stress pathways.
Interestingly, data revealed that the reduced expression of
the UPR genes could influence the progression of OA
under homeostatic (H)-UPR conditions, in which ERN1,
PERK, and CREB3L2 can act as regulators of some colla-
gens/MMPs. As the decrease in PERK favours a reduced
expression of type II collagen (COL2a1) and increased
type I collagen, these findings lead us to propose PERK as
a potential target for OA therapeutic strategies. However,
further studies are needed to confirm this finding.
Our finding that OA cells are not characterized by an
increased activation of the ER stress response is in con-
trast to previous reports suggesting that GRP78 and
phosphorylated PERK increased with the severity of
cartilage degeneration [15, 16]. However, Takada et al
[15] only looked at OA cartilage and indeed detected
activated pPERK in this tissue, as we found in our OA
samples. The amount of pPERK in our OA samples,
however, was not greater than that found in the normal
cartilage. Takada et al [15] also investigated the pres-
ence, by gel electrophoresis, of the XBP1 spliced form.
They looked at OA human cartilage samples but from
different regions named mild, moderate, and severe de-
generation from the same knee. They showed that the
spliced form of XBP1 was barely or not at all detectable
in the mild and severe regions of the cartilage. Although
present in moderate OA cartilage, it was less abundant
than the unspliced form, indicating that the XBP1 spliced
form was not the major form expressed. In our study, we
used cartilage samples taken from the whole OA knee to
obtain a global picture of XBP1 activity and did not detect
the spliced form.
We have shown that PDGF-BB and IL-6 will add to the
degenerative process of OA through the downregulation
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of ERN1 and PERK, which, in turn, will affect collagen
expression. This finding adds to the known effects of
PDGF-BB on chondrocyte proliferation, differentiation
and proteoglycan production [28], and downregulation
of the IL-1β-induced nuclear factor kappa B (NF-kB)
signalling [29]. Data also revealed a new role for IL-6,
known as an independent predictor of the appearance
of knee OA, for its association with local inflammation
[30, 31], and for its capacity to downregulate the ex-
pression of type II collagen [32]. As we have shown that
IL-6 decreases ERN1 and PERK expression and that a
decrease in these two proteins leads to a decreased ex-
pression of type II collagen, these data illustrate the
versatility of action of this cytokine on type II collagen
expression in OA chondrocytes.
The finding that IL-1β upregulated ERN1 and PERK
was unexpected, considering that their expression was
decreased in OA chondrocytes and that IL-1β is known
to be increased in diseased cartilage [27]. It is possible
that the increased presence of PDGF-BB in the OA
cartilage [33] would have a threefold effect: a decreased
expression of ERN1 and PERK by directly reducing their
expression, a decreased IL-1β expression as our results
have shown, and an interference with the stimulatory ef-
fect of IL-1β on those genes [29].
An emerging finding is that, under homeostasis, the
decreased expression of the UPR genes ERN1, PERK,
ATF6B, and CREB3L2 in human chondrocytes will affect
the regulation of some collagens/MMPs. As reported in
other systems, PERK and ERN1 play dual roles depending
on whether they are activated by physiological factors or
by ER stress and the cellular response will differ depend-
ing on the stimuli. For instance, Lipson et al [12] reported
that activation of ERN1 in pancreatic β cells transiently
exposed to high glucose resulted in an increased insulin
biosynthesis not involving the activation of the ER stress
response, but that a chronic exposure to high glucose trig-
gered the ER stress response and the suppression of the
insulin gene expression. Another example of the role of
UPR genes in the absence of ER stress has been shown in
Fig. 4 Effect of silencing UPR genes under H-UPR conditions in human osteoarthritic chondrocytes. a Silencing (si) ERN1, PERK, ATF6B, and CREB3L2
(Western blots), and the resulting expression of COL1a1, COL2a1, MMP-1, MMP-13, ADAMTS4, and ADAMTS5 (qPCR) (n = 7–10). The non-targeting or
random siRNA (siNT) values were calculated for each primer as fold change over the control, which was assigned an arbitrary value of 1, and the
mean ± SEM was 1.02 ± 0.03 for all the primers grouped. b Effect of IL-1β (100 pg/ml) with or without (control) siPERK, siATF6B, and siCREB3L2
on COL2a1, ADAMTS4, and ADAMTS5 levels (n = 5–7). Each control was assigned an arbitrary value of 1 and the effect of the treatment evaluated as
fold change over control. Also represented are the siNTs for COL2a1, ADAMTS4, and ADAMTS5 respectively, showing values similar to those of the
control. Data are expressed as mean ± SEM, and p values were assessed by the one-sample t test, comparing the treated chondrocytes to
the control
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endothelial cells, where vascular endothelial growth factor
(VEGF) signals through ATF6 and PERK via the mamma-
lian target of rapamycin complex 1 (mTORC1) complex
[13]. In the present study, we identify ERN1 and PERK as
regulators of collagen and protease expression in OA
chondrocytes under H-UPR conditions. The regulation of
collagen synthesis in chondrocytes is crucial as the type of
collagen produced influences the quality of the cartilage
matrix. In OA, there is a loss of the structural collagen,
the type II, and an increase in type I collagen known to
weaken the cartilage, which undermine the integrity of the
extracellular cartilage matrix, in turn affecting the
cartilage properties. Our data showing that a decreased
expression of ERN1 and PERK in OA chondrocytes
could induce a decreased expression of type II collagen
and, in the case of PERK, an increased expression of
type I collagen, are of great importance as this would
favour a microenvironment change in the extracellular
matrix and contribute to the degeneration process. In
turn, increasing the molecules ERN1 and PERK in OA
cartilage could be foreseen as having therapeutic poten-
tial. However, as ERN1, ATF6B, and CREB3L2 affect
proteases involved in cartilage degradation, their usage
during OA could be detrimental. In contrast, an increase
in PERK, in addition to acting in a reverse manner on
both types of collagen, could also counteract the inhibi-
tory effect of IL-1β on type II collagen.
Conclusions
In conclusion, we showed that the level of ER stress is not
significantly elevated in OA chondrocytes. Furthermore,
under I-UPR conditions, OA chondrocytes respond
strongly to ER stress despite the decreased expression
of several ER stress genes. Importantly, and for the first
time, this study reveals new roles for ERN1, PERK, ATF6B,
and CREB3L2 in cartilage under H-UPR conditions as reg-
ulators of collagen and/or protease genes, and identifies
PERK as a potential target for new therapeutic strategies
for OA as increasing PERK may lead to an increase in type
II collagen and a decrease in type I collagen expression
and, in so doing, could restore to some extent homeostatic
conditions in OA cartilage.
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